2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Stentys Self-Apposing Stent Evaluated for CLI Treatment

January 28, 2015 -- Stentys announced that its Self-Apposing drug-eluting stent was evaluated in 70 patients with critical limb ischemia (CLI) and prevented foot amputation in…

Robert Califf, MD, Named FDA Deputy Commissioner

January 26, 2015 -- The US Food and Drug Administration (FDA) announced that FDA Commissioner Margaret A. Hamburg, MD, has appointed Robert Califf, MD, as FDA deputy commissio…

InspireMD’s CGuard RX Approved in Europe, 6-Month CARENET Data Presented

January 27, 2015 -- InspireMD, Inc. announced that it received European CE Mark approval for the CGuard RX rapid exchange system for the company’s MicroNet covered carot…

Biosensors to Distribute Veryan’s BioMimics 3D Stent

January 28, 2015 -- Biosensors International Group announced an agreement with Veryan Medical Ltd. to distribute Veryan’s BioMimics 3D, a nitinol stent with three-dimens…

Early Results Presented at STS for Gore’s Thoracic Single Side Branch Endograft

January 27, 2015 -- A novel approach for treating thoracic aortic aneurysms was presented at the 51st Annual Meeting of the Society of Thoracic Surgeons (STS), the society ann…

Intact Vascular’s Tack Endovascular System Supported by 12-Month TOBA Data

January 27, 2015 -- Intact Vascular, Inc. announced that 12-month results from the TOBA (Tack Optimized Balloon Angioplasty) clinical trial were presented by Coprincipal …

Spectranetics Launches Stellarex DCB in Europe

January 27, 2015 -- Spectranetics Corporation announced the European launch of its Stellarex drug-coated balloon in Europe. The launch follows the completion of Spectranetics&…

Click here for more News coverage

Current Supplement

Sponsored by Covidien


Why Directional Atherectomy Matters With Anti-Restenotic Therapies

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $44.76  3.11%
AstraZeneca PLC $71.04  0.04%
Boston Scientific Corporation $14.81  1.51%
BTG plc $791.00  -0.50%
Cardiovascular Systems Inc. $34.09  10.79%
Covidien plc $106.71  0.00%
CR Bard Inc. $171.03  -2.35%
Edwards Lifesciences Corp. $125.35  -2.73%
Endologix Inc. $13.93  -2.11%
Hansen Medical, Inc. $0.90  7.77%
Vascular Market Price  Change
Johnson and Johnson $100.14  -1.32%
Lombard Medical, Inc. $5.08  -1.93%
Medtronic, Inc. $71.40  -2.74%
Merit Medical Systems, Inc. $15.33  -0.39%
St. Jude Medical Inc. $65.87  -2.26%
The Medicines Company $28.67  0.46%
The Spectranetics Corporation $32.71  -3.82%
TriVascular Technologies, Inc. $9.78  6.07%
Vascular Solutions Inc. $27.26  -3.84%
Volcano Corporation $10.30  1.78%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media